New Hampshire House Bill HB1192

New Hampshire 2026 Regular Session

• Introduced: 12/1/25
• Refer: 12/1/25
• Report Pass: 2/20/26
• Engrossed: 3/6/26
• Refer: 3/6/26
• Report Pass: 4/17/26

Caption

Exempting certain household pharmaceutical wastes from the definition of hazardous waste.

Impact

The bill's proposed amendment to existing regulations is expected to have a notable impact on both the environment and healthcare sectors. By removing household pharmaceutical wastes from the hazardous waste category, it could reduce the regulatory burden on residents and allow for more accessible waste management practices. This is particularly relevant as the proper disposal of pharmaceuticals is increasingly critical in preventing water contamination and addressing public health concerns related to improper disposal methods.

Summary

House Bill 1192 aims to exempt certain household pharmaceutical wastes from the definition of hazardous waste under the state's hazardous waste management statutes. By specifying that household pharmaceutical wastes collected pursuant to existing state law are not to be classified as hazardous, the bill seeks to simplify the disposal processes for these materials. This legislative change is positioned as a means to improve public health and safety by facilitating appropriate disposal methods for everyday pharmaceutical products that are no longer needed.

Sentiment

Overall, sentiment surrounding HB 1192 appears to be generally supportive among stakeholders who advocate for more straightforward waste management options. Supporters argue that this exemption will encourage better disposal of pharmaceuticals among everyday consumers, potentially reducing the risks associated with improper disposal. However, there may be opposing views from environmental advocates who express concerns about the potential impacts of allowing more pharmaceutical waste to be regarded as non-hazardous, thereby complicating the state’s overall strategy for hazardous waste management.

Contention

Key points of contention in discussions about HB 1192 may revolve around the adequacy of current waste management protocols and the potential consequences of exempting pharmaceutical waste from hazardous classifications. Opponents may argue that the exemption could lax enforcement of critical environmental protections, ultimately leading to increased environmental pollution or health risks. Therefore, while proponents seek to promote convenience and safety for residents, opponents may worry that such a legislative move could overlook essential environmental safeguards in favor of regulatory simplification.